Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px
Organisation › Details

Cevec (Group)

CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system. CAP®GT is a fully scalable manufacturing platform for viral vector production. CEVEC has successfully developed CAP®GT suspension cell-derived viral packaging cell lines, including a stable, helper virus-free AAV production platform, which enable better scale-up and competitive production costs when compared to adherent cell culture systems. CAP®GT suspension cell lines grow to high cell densities and show excellent productivity for a broad range of viruses. Gene therapy vectors such as lentiviral, adenoviral, and adeno-associated viral (AAV) vectors can be produced at industrial scale. CAP®Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP®Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns. *

 

Period Start 2001-01-01 established
  Today Cevec Pharmaceuticals GmbH
Products Industry cell line/system (recombinant protein production)
  Industry 2 CAP® technology (Cevec)
Persons Person Faust, Nicole (Cevec 201904 CEO + CSO joined Cevec 201105 before amaxa + Artemis Pharmaceuticals)
  Person 2 Kettling, Ulrich (Cevec 202004 CBO)
     
Region Region Köln (Cologne)
  Country Germany
  Street 62 Gottfried-Hagen-Str.
  City 51105 Köln
  Tel +49-221-460208-00
    Address record changed: 2020-12-11
     
Basic data Employees B: 11 to 50 (2010-01-01)
     
    * Document for �About Section�: Cevec Pharmaceuticals GmbH. (4/16/19). "Press Release: Cevec Closes Major Financing Round to Further Expand and Commercialize Its Viral Vector Manufacturing Platform". Cologne.
     
   
Record changed: 2020-12-11

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Cevec (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] Made Without Love 650x80px




» top